Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  IMAC Holdings, Inc.    IMAC

IMAC HOLDINGS, INC.

(IMAC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

IMAC HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
08/06/2020 | 05:49pm EDT

Item 8.01 Other Events.

On August 5, 2020, IMAC Holdings, Inc. (the "Company") issued a press release announcing the approval by the United States Food and Drug Administration (the "FDA") of the Company's investigational new drug application, which IMAC submitted in May 2020, for the use of umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia, or the gradual loss and slowing down of spontaneous body movement, due to Parkinson's disease. Pursuant to the FDA's approval, the Company anticipates beginning a phase 1 clinical trial of its stem cell treatment within 30 days. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Cautionary Note Regarding Forward-Looking Statements

The information contained in this Current Report on Form 8-K and the exhibits attached hereto contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements related to the benefits of the Transaction. The words "intend," "may," "should," "would," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other comparable terminology are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. While the Company believes its plans, intentions and expectations reflected in those forward-looking statements are reasonable, these plans, intentions or expectations may not be achieved. The Company's actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements. For information about the factors that could cause such differences, please refer to the Company's filings with the U.S. Securities and Exchange Commission. Given these uncertainties, you should not place undue reliance on these forward-looking statements. The Company assumes no obligation to update any forward-looking statement.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits

    Exhibit No. Description

99.1 Press Release, dated August 5, 2020.

© Edgar Online, source Glimpses


share with twitter share with LinkedIn share with facebook
All news about IMAC HOLDINGS, INC.
10/23IMAC HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
10/16IMAC HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued List..
AQ
10/07IMAC HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form ..
AQ
10/05IMAC HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/23IMAC : Partners with Safe Balance, LLC to Provide Services that Improve Balance ..
AQ
09/23IMAC Holdings, Inc. Partners with Safe Balance, LLC to Provide Services that ..
GL
09/15IMAC Holdings Announces Update to Service Locations
GL
09/15IMAC : Announces Update to Service Locations
AQ
09/08IMAC HOLDINGS, INC. : Other Events (form 8-K)
AQ
08/25IMAC Holdings to Present at the LD Micro 500 Virtual Conference on September ..
GL
More news
Financials (USD)
Sales 2020 14,0 M - -
Net income 2020 -7,50 M - -
Net Debt 2020 - - -
P/E ratio 2020 -1,15x
Yield 2020 -
Capitalization 9,41 M 9,41 M -
Capi. / Sales 2020 0,67x
Capi. / Sales 2021 0,52x
Nbr of Employees 120
Free-Float 61,0%
Chart IMAC HOLDINGS, INC.
Duration : Period :
IMAC Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IMAC HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 4,50 $
Last Close Price 0,80 $
Spread / Highest target 466%
Spread / Average Target 466%
Spread / Lowest Target 466%
EPS Revisions
Managers
NameTitle
Jeffrey S. Ervin Chairman & Chief Executive Officer
Matthew C. Wallis Chief Operating Officer & Director
Sheri Gardzina Secretary, Chief Financial & Accounting Officer
George P. Hampton Independent Director
David K. Ellwanger Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IMAC HOLDINGS, INC.-47.00%9
AIER EYE HOSPITAL GROUP CO., LTD.101.97%37 777
FRESENIUS SE & CO. KGAA-33.44%22 035
IHH HEALTHCARE-5.85%10 857
TOPCHOICE MEDICAL CORPORATION116.05%10 593
RAMSAY HEALTH CARE LIMITED-13.28%10 232